MedTrace Logo

Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness

NCT07536035 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2026-04-17

No results posted yet for this study

Summary

Every country in the world is experiencing growth in both the size and the proportion of older persons. As a result of the changes, the profile and needs of people with medical illnesses have evolved. How care is delivered to patients has to keep pace with these changes, or patients will experience poor care at high cost and not have their needs met. A new model of care has emerged to meet these challenges: Acute Medical Unit. Despite considerable investment and popularity of this model, questions remain: (i) Who benefits most from this care model? (ii) How may these models be most effectively implemented for the best results? (iii) How effective are these models? Singapore is well-placed to answer these questions with its national healthcare system and excellent research institutions. The investigators plan to study how effective the model is by comparing patients with similar profiles exposed to both these care models compared to how hospital care is usually provided, looking for four differences: (i) how long patients stay in hospital, (ii) how often they use the emergency department (iii) quality of health (iv) cost. Additionally, the investigators seek to characterise patterns of health needs for this group of patients.

Conditions

  • Falls Injury
  • Falls
  • Hospitalization in Acute Care
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Infection
  • Acute Exacerbation of Asthma
  • Pneumonia
  • UTI - Urinary Tract Infection
  • URTI - Viral Upper Respiratory Tract Infection

Sponsors & Collaborators

  • Duke-NUS Graduate Medical School

    collaborator OTHER

  • National University Hospital, Singapore

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07536035 on ClinicalTrials.gov